Aaron Weaver
Director/Board Member chez BIONOMICS LIMITED
Fortune : - $ au 31/03/2024
Profil
Aaron N.
D.
Weaver is currently an Independent Non-Executive Director at Bionomics Ltd., a Director at Interactive Strength, Inc., a Director at Endogena Therapeutics, Inc., a Director at Leaf4life LLC, a Member-Supervisory Board at MagForce AG, the Head-Capital Markets at Apeiron Investments SCA, and a Principal at Apeiron Investment Group Ltd.
Previously, he was a Director at Alto Neuroscience, Inc. and served as the Senior General Counsel & Investor Relations Lead at ATAI Life Sciences AG from 2019 to 2021.
Mr. Weaver completed his undergraduate degree at The University of Queensland in 2003 and his graduate degree at Queensland University of Technology in 2006.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
INTERACTIVE STRENGTH INC
-.--% | 07/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Aaron Weaver
Sociétés | Poste | Début |
---|---|---|
BIONOMICS LIMITED | Director/Board Member | 06/07/2020 |
MAGFORCE AG | Director/Board Member | - |
INTERACTIVE STRENGTH INC. | Director/Board Member | - |
Endogena Therapeutics, Inc.
Endogena Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Endogena Therapeutics, Inc. develops endogenous regenerative medicines. The company was founded by Matthias Steger and Gisbert Schneideri and is headquartered in San Francisco, CA. | Director/Board Member | - |
Apeiron Investments SCA | Corporate Officer/Principal | 01/05/2019 |
Leaf4life LLC | Director/Board Member | - |
Apeiron Investment Group Ltd. /Private Equity/
Apeiron Investment Group Ltd. /Private Equity/ Investment ManagersFinance Apeiron Investment Group Ltd /Private Equity/ (Apeiron Investment Group) is a private equity subsidiary of Apeiron Investment Group Ltd founded in 2012 by Christian Angermayer. The firm is headquartered in Sliema, Malta. | Corporate Officer/Principal | 01/06/2021 |
Anciens postes connus de Aaron Weaver
Sociétés | Poste | Fin |
---|---|---|
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany. | Investor Relations Contact | 01/06/2021 |
ALTO NEUROSCIENCE, INC. | Director/Board Member | - |
Formation de Aaron Weaver
The University of Queensland | Undergraduate Degree |
Queensland University of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
BIONOMICS LIMITED | Health Technology |
MAGFORCE AG | Health Technology |
ALTO NEUROSCIENCE, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Apeiron Investments SCA | |
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany. | Health Technology |
Interactive Strength, Inc. | |
Apeiron Investment Group Ltd. /Private Equity/
Apeiron Investment Group Ltd. /Private Equity/ Investment ManagersFinance Apeiron Investment Group Ltd /Private Equity/ (Apeiron Investment Group) is a private equity subsidiary of Apeiron Investment Group Ltd founded in 2012 by Christian Angermayer. The firm is headquartered in Sliema, Malta. | Finance |
Endogena Therapeutics, Inc.
Endogena Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Endogena Therapeutics, Inc. develops endogenous regenerative medicines. The company was founded by Matthias Steger and Gisbert Schneideri and is headquartered in San Francisco, CA. | Health Technology |
Leaf4life LLC |